Lipedema
Conditions
Interventions
This study is a primary, interventional, double-blind randomized clinical trial. Randomization was performed using a lottery system involving letters from A to T. Participants assigned letters A throu
E02.774
Sponsors
Hospital da Bahia S/A - Assistência Médica e Hospitalar
Clínica Vascular Takayanagi
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Female patients; patients with lipedema classified as mild to moderate; presence of pain in adipose tissue in the extremities; age between 18 and 70 years; patients able to understand and sign the informed consent form prior to undergoing photobiomodulation
Exclusion criteria
Exclusion criteria: Male patients; patients who do not sign the informed consent form; patients without pain in the extremities secondary to lipedema; patients using analgesics or anti-inflammatory drugs; pregnant patients; patients with infection or malignant lesions at the application site
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the impact of phototherapy on pain reduction, as measured by the Visual Analog Scale applied before and after the interventions | — |
Secondary
| Measure | Time frame |
|---|---|
| Is expected to be observed the impact of phototherapy on medium-term pain reduction as measured by the Visual Analog Scale during follow-up assessments at thirty and ninety days post-interventions;Is expected to be observed the impact of phototherapy on improvement of quality of life, as assessed by the SF-36 questionnaire administered before, after, and 90 days following the intervention | — |
Countries
Brazil
Contacts
Public ContactMiriam Gomez
Clínica Vascular Takayanagi
Outcome results
None listed